Disclosure of Genetic Risk for Salt Sensitivity
Does Disclosing Genetic Risk to Salt Sensitivity Increase Compliance to Personalised Dietary Recommendations?
1 other identifier
interventional
35
0 countries
N/A
Brief Summary
The global burden of cardiovascular disease (CVD) has decreased over the past 10 years. Nevertheless, the disease still kills one in three people. Hypertension is one of the leading causes of cardiovascular disease, with salt in the diet being a main contributor. Depending on an individual's DNA, participants may or may not be salt sensitive. Genotyping individuals for variants in a salt sensitivity gene (SLC4A5) may identify salt sensitive individuals which may benefit from a personalised dietary advice to reduce salt intake. Adherence to such advice can then be assessed which may aid in prevention of hypertension and CVD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2019
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2018
CompletedFirst Posted
Study publicly available on registry
December 14, 2018
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedDecember 14, 2018
December 1, 2018
2 months
September 21, 2018
December 13, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Dietary salt intake
24-hour recall
1 month
Study Arms (2)
Low genetic risk group
EXPERIMENTALDietary advice to maintain salt intake to 6g/day
High genetic risk group
EXPERIMENTALDietary advice to reduce salt intake to 4g/day
Interventions
Based on their genetic risk, participants are given advice to either adhere to general dietary guidelines related to salt intake or to reduce their salt intake to no more than 4 grams per day.
Eligibility Criteria
You may qualify if:
- healthy males and females, aged 18-35
You may not qualify if:
- pregnant, CVD events (Angina, myocardial infarction, heart failure) or stage 2, hypertension, a BMI ≥30kg/m2, or experiencing mental anguish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Administrator
Study Record Dates
First Submitted
September 21, 2018
First Posted
December 14, 2018
Study Start
February 1, 2019
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
December 14, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share